CSIMarket
 
Clearpoint Neuro Inc   (CLPT)
Other Ticker:  
 
 
Price: $7.0700 $-0.08 -1.119%
Day's High: $7.205 Week Perf: 16.86 %
Day's Low: $ 6.93 30 Day Perf: -5.1 %
Volume (M): 106 52 Wk High: $ 10.95
Volume (M$): $ 746 52 Wk Avg: $6.82
Open: $7.20 52 Wk Low: $4.05



 Market Capitalization (Millions $) 174
 Shares Outstanding (Millions) 25
 Employees -
 Revenues (TTM) (Millions $) 24
 Net Income (TTM) (Millions $) -22
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 1

Clearpoint Neuro Inc
Clearpoint Neuro Inc. is a medical technology company that focuses on developing and commercializing innovative solutions for neurosurgery and neurology. The company's main product is the ClearPoint Neuro Navigation System, a platform used to perform minimally invasive brain surgeries with real-time MRI guidance.

ClearPoint's system provides precise targeting and visualization during brain procedures, enabling surgeons to perform interventions with increased accuracy and safety. The company's technology is utilized in a range of neurosurgical applications such as biopsies, ablations, and electrode implantations for deep brain stimulation.

ClearPoint also offers a software suite called ClearTrace, which provides real-time monitoring and analysis of brain tissue during procedures. This software assists in optimizing therapeutic interventions and improves patient outcomes.

ClearPoint Neuro Inc. is dedicated to advancing the field of neurosurgery by improving patient care and facilitating the development of new therapies. They collaborate with leading medical centers, researchers, and technology companies to drive innovation and support the growth of the neurosurgical field.


   Company Address: 120 S. Sierra Ave. Solana Beach 92075 CA
   Company Phone Number: 287-9109   Stock Exchange / Ticker: NASDAQ CLPT
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Clearpoint Neuro Inc

Struggling to Turn a Profit: Despite Revenue Surge, Company Fails to See Financial Growth

Clearpoint Neuro Inc stock has experienced a significant drop of -23.2% over the past year, bringing the share price to a decrease of 1.48% in the past 90 days. Currently trading on the NASDAQ, the stock is -9.8% below its 52-week average.
A contributing factor to the decline in stock price is the increased losses reported by Clearpoint Neuro Inc. In the most recent fiscal period, the company reported losses of $-0.19 per share, an increase from the previous quarter where losses were reported at $-0.20 per share. However, there is a silver lining as revenue surged by 31.62% to $6.81 million compared to the same period a year prior when revenue was $5.76 million.

Clinical Study

Revolutionizing Neurosurgery: ClearPoint Neuro's Prism Neuro Laser Therapy System Shatters Boundaries with Unparalleled Precision and Software-Histopathology Correlation

Published Mon, Mar 11 2024 12:01 PM UTC

Journal of Neurosurgery Publication Highlights ClearPoint Prism Neuro Laser Therapy System's Unparalleled Efficiency and PrecisionIn an exciting development, ClearPoint Neuro has recently released a peer-reviewed publication in the esteemed Journal of Neurosurgery showcasing the remarkable advantages of their innovative ClearPoint Prism Neuro Laser Therapy System. The study,...

Shares

ClearPoint Neuro Announces Pricing of Public Stock Offering, Represents New Opportunities for Global Medical Device Innovations

Published Thu, Feb 29 2024 1:00 PM UTC



SOLANA BEACH, Calif., Feb. 29, 2024 - ClearPoint Neuro, Inc. (Nasdaq: CLPT), a pioneering global medical device, cell, and gene therapy-enabling company, has recently announced the pricing of its underwritten public offering of 2,307,694 shares of common stock. With an offering price of $6.50 per share, these shares are expected to generate substantial interest wit...

Stock Market Announcement

ClearPoint Neuro, Inc. Seeks Public Offering of Common Stock to Drive Growth and Innovation

Published Wed, Feb 28 2024 9:46 PM UTC

ClearPoint Neuro, Inc. Announces Proposed Public Offering of Common Stock
ClearPoint Neuro, Inc., a leading global device, cell, and gene therapy-enabling company specializing in precise navigation to the brain and spine, has just announced the commencement of a proposed underwritten public offering of its shares of common stock. The offering will consist of all shares o...

Product Service News

ClearPoint Neuro Strengthens Neurosurgery with FDA Clearance and Breakthrough Software Integration, Gaining EU MDR Certification and Expanding into Operating Room Technology

Published Wed, Feb 21 2024 9:05 PM UTC

ClearPoint Neuro, a leading medical technology company specializing in advanced neuroscience solutions, has recently achieved a series of significant milestones that are set to transform the field of neurosurgery. The company has announced the FDA clearance and successful first-in-human cases using the highly anticipated 2.2 Software version, uniquely integrated with the rev...






 

Clearpoint Neuro Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Clearpoint Neuro Inc does not provide revenue guidance.

Earnings Outlook
Clearpoint Neuro Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com